speb/financial-data huggingface dataset:
DML.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1131000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 402902000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 402902000.00
DML.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -341707.61
DML.TO income_statement (quarterly, 2025-09-30) — Tax Provision: -421000.00
DML.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 1107175000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 697730000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 294828000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 402902000.00
DML.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 23148000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 704273000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 607271000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 662520000.00
DML.TO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 772000.00
DML.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -109887000.00
DML.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -109887000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -16170000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 458151000.00
DML.TO income_statement (annual, 2025-12-31) — +Operating Expense: 90906000.00
DML.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 24181000.00
DML.TO income_statement (annual, 2025-12-31) — +Total Revenue: 4918000.00
DML.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 1222000.00
DML.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 19968000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 19968000.00
DML.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 5332000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 5332000.00
DML.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -49881000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -49881000.00
DML.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 76229000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 76229000.00
DML.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 5951000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 5951000.00
DML.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 896600000.00
DML.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.24
DML.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 108518000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 471258000.00
DML.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -50496000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -31404000.00
DML.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 1683831000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1683831000.00
DML.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 465918000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 465918000.00
DML.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 539439000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 539439000.00
DML.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 452328000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 452328000.00
DML.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 13590000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 13590000.00
DML.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 474283000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 14748000.00
DML.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -49517000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -10739000.00
DML.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -68148000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -8434000.00
DML.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -6600000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -3336000.00
DML.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 10436000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 7870000.00
DML.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -314000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -914000.00
DML.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -2714000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1720000.00
DML.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 808000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 5340000.00
DML.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 356618000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4425000.00
DML.TO balance_sheet (annual, 2025-12-31) — Common Stock: 1683831000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 1683831000.00
DML.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 368370000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 368370000.00
DML.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 14496000.00
DML.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7645000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7645000.00
DML.TO balance_sheet (annual, 2025-12-31) — Current Assets: 560233000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 560233000.00
DML.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 4517000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 4517000.00
DML.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 4517000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 4517000.00
DML.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 52121000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 52121000.00
DML.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 1060000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 1060000.00
DML.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -6632000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -104000.00
DML.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -6632000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -104000.00
DML.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 17773000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7049000.00
DML.TO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 316444000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 316444000.00
DML.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 896600000.00
DML.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.24
DML.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -217288000.00
DML.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -51287000.00
DML.TO balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 8999000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 8999000.00
DML.TO income_statement (annual, 2025-12-31) — EBIT: -208677000.00
DML.TO income_statement (quarterly, 2025-12-31) — EBIT: -41159000.00
DML.TO income_statement (annual, 2025-12-31) — EBITDA: -190904000.00
DML.TO income_statement (quarterly, 2025-12-31) — EBITDA: -34110000.00
DML.TO income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -2985000.00
DML.TO income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -182000.00
DML.TO cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 1213000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 33000.00
DML.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 782000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -915000.00
DML.TO cash_flow (annual, 2025-12-31) — End Cash Position: 465918000.00
DML.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 465918000.00
DML.TO balance_sheet (annual, 2025-12-31) — Financial Assets: 47993000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 47993000.00
DML.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 474283000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 14748000.00
DML.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -118644000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -39838000.00
DML.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 112186000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 21496000.00
DML.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 18000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 18000.00
DML.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 18000.00
DML.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -129418000.00
DML.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -24524000.00
DML.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1598000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1598000.00
DML.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 19564000.00
DML.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6554000.00
DML.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 366807000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 366807000.00
DML.TO balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 11768000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 11768000.00
DML.TO income_statement (annual, 2025-12-31) — Interest Expense: 15243000.00
DML.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 10232000.00
DML.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 15243000.00
DML.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 10232000.00
DML.TO income_statement (annual, 2025-12-31) — Interest Income: 8387000.00
DML.TO income_statement (quarterly, 2025-12-31) — Interest Income: 3300000.00
DML.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 8387000.00
DML.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3300000.00
DML.TO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 7645000.00
DML.TO balance_sheet (annual, 2025-12-31) — Interest Payable: 7645000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Interest Payable: 7645000.00
DML.TO balance_sheet (annual, 2025-12-31) — Inventory: 12267000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 12267000.00
DML.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 664090000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 664090000.00
DML.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -49517000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -10739000.00
DML.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 17719000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 17719000.00
DML.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 165885000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 165885000.00
DML.TO balance_sheet (annual, 2025-12-31) — Investmentsin Joint Venturesat Cost: 19450000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Investmentsin Joint Venturesat Cost: 19450000.00
DML.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 14496000.00
DML.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 458994000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
DML.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 295720000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 295720000.00
DML.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 295720000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 295720000.00
DML.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 458994000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
DML.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -517000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -158000.00
DML.TO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 19450000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 19450000.00
DML.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 33544000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 33544000.00
DML.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 165205000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 165205000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -4299000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -2601000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 14496000.00
DML.TO balance_sheet (annual, 2025-12-31) — Net Debt: 146246000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 146246000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -2835000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -3432000.00
DML.TO income_statement (annual, 2025-12-31) — Net Income: -217288000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Income: -51287000.00
DML.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -217288000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -51287000.00
DML.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -217288000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -51287000.00
DML.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
DML.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -217288000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -51287000.00
DML.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -217288000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -51287000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -217288000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -51287000.00
DML.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -217288000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -51287000.00
DML.TO income_statement (annual, 2025-12-31) — Net Interest Income: -9532000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -7341000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 5429000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 23085000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 458477000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -158000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 458477000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -158000.00
DML.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -9532000.00
DML.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -7341000.00
DML.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -206000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 126000.00
DML.TO balance_sheet (annual, 2025-12-31) — Net PPE: 316926000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 316926000.00
DML.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -50441000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -31349000.00
DML.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 368370000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 368370000.00
DML.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 37217000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 37217000.00
DML.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 35628000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 35628000.00
DML.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1589000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1589000.00
DML.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: -61504000.00
DML.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -9604000.00
DML.TO income_statement (annual, 2025-12-31) — Normalized Income: -91720533.05
DML.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -26830592.81
DML.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -68148000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -8434000.00
DML.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 110582000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 18115000.00
DML.TO income_statement (annual, 2025-12-31) — Operating Income: -85988000.00
DML.TO income_statement (quarterly, 2025-12-31) — Operating Income: -22959000.00
DML.TO income_statement (annual, 2025-12-31) — Operating Revenue: 4918000.00
DML.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 1222000.00
DML.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 901610950.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 901610950.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 3195000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3195000.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 5342000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 5342000.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1598000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1598000.00
DML.TO income_statement (annual, 2025-12-31) — Other Gand A: 19564000.00
DML.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 6554000.00
DML.TO income_statement (annual, 2025-12-31) — Other Income Expense: -128400000.00
DML.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -21091000.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Investments: 128716000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Investments: 128716000.00
DML.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 36044000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 4714000.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 15037000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 15037000.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 2658000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 2658000.00
DML.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3985000.00
DML.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 3597000.00
DML.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 71342000.00
DML.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 17627000.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Payable: 4590000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 4590000.00
DML.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 73521000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 73521000.00
DML.TO balance_sheet (annual, 2025-12-31) — Payables: 33557000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Payables: 33557000.00
DML.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 41202000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 41202000.00
DML.TO income_statement (annual, 2025-12-31) — Pretax Income: -223920000.00
DML.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -51391000.00
DML.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1310000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 158000.00
DML.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -4299000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -2601000.00
DML.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -48822000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
DML.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -50496000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -31404000.00
DML.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 12267000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 12267000.00
DML.TO balance_sheet (annual, 2025-12-31) — Receivables: 5332000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 5332000.00
DML.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 17773000.00
DML.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7049000.00
DML.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -517000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -158000.00
DML.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -1393288000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1393288000.00
DML.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 54251000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 23085000.00
DML.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 55000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 55000.00
DML.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 19564000.00
DML.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6554000.00
DML.TO balance_sheet (annual, 2025-12-31) — Share Issued: 901610950.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 901610950.00
DML.TO income_statement (annual, 2025-12-31) — Special Income Charges: 18000.00
DML.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 4747000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1130000.00
DML.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 368370000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 368370000.00
DML.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 368370000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 368370000.00
DML.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3832533.05
DML.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -49592.81
DML.TO income_statement (annual, 2025-12-31) — Tax Provision: -6632000.00
DML.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -104000.00
DML.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.03
DML.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
DML.TO balance_sheet (annual, 2025-12-31) — Total Assets: 1106074000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 1106074000.00
DML.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 664090000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 664090000.00
DML.TO balance_sheet (annual, 2025-12-31) — Total Debt: 295720000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 295720000.00
DML.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 368370000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 368370000.00
DML.TO income_statement (annual, 2025-12-31) — Total Expenses: 90906000.00
DML.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 24181000.00
DML.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 737704000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 737704000.00
DML.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 545841000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 545841000.00
DML.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 685583000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 685583000.00
DML.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 2676000.00
DML.TO income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 409000.00
DML.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -129400000.00
DML.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -24506000.00
DML.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -129400000.00
DML.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -24506000.00
DML.TO cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -14182000.00
DML.TO cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 6609000.00
DML.TO balance_sheet (annual, 2025-12-31) — Working Capital: 508112000.00
DML.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 508112000.00
DML.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 22439000.00
DML.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 1106000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 23668000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 6616000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -51233000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 75705000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 5879000.00
DML.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 903094000.00
DML.TO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.13
DML.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 465918000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -14186000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1690896000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 418493000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 561394000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 408789000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 9704000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2933000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -15595000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -35507000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: 1182000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -12320000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -452000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1284000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -12874000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -48169000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 1690896000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 260140000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 42765000.00
DML.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1459000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 771000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 585110000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 4500000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 4500000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 42483000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Current Provisions: 1060000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -4730000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -4730000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Depletion: 5718000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5718000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 424883000.00
DML.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 903094000.00
DML.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.13
DML.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -114879000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 7148000.00
DML.TO income_statement (quarterly, 2026-03-31) — EBIT: -108718000.00
DML.TO income_statement (quarterly, 2026-03-31) — EBITDA: -103000000.00
DML.TO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -786000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 570000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 744000.00
DML.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 418493000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Financial Assets: 61211000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2933000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -49693000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 95221000.00
DML.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -88090000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 1706000.00
DML.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5840000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 387952000.00
DML.TO income_statement (quarterly, 2026-03-31) — Gross Profit: -353000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 12298000.00
DML.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 10891000.00
DML.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 10891000.00
DML.TO income_statement (quarterly, 2026-03-31) — Interest Income: 3513000.00
DML.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3513000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Interest Payable: 771000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 13115000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 565252000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -15595000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 18177000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 108008000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 19736000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 305112000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 305112000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -116000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 19736000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 33855000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 140920000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -856000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 3540000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Income: -114879000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -114879000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -114879000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -114879000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -114879000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -114879000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -114879000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -7378000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -116000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -116000.00
DML.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -7378000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -26000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -553000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 336719000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -14186000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 260140000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 37235000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 35646000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1589000.00
DML.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -14910000.00
DML.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -30272564.78
DML.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -35507000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 99331000.00
DML.TO income_statement (quarterly, 2026-03-31) — Operating Income: -22792000.00
DML.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 1106000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 904284630.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3985000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 589000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 1706000.00
DML.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 5840000.00
DML.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -89439000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Investments: 70095000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 465000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 15262000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2602000.00
DML.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -563000.00
DML.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 16599000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 4747000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 2254000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 142901000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Payables: 35563000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 36334000.00
DML.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -119609000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 3075000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -856000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -14186000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 13115000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 6616000.00
DML.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1459000.00
DML.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5718000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -116000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1508167000.00
DML.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5840000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 904284630.00
DML.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1917000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 260140000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 260140000.00
DML.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -3483564.78
DML.TO income_statement (quarterly, 2026-03-31) — Tax Provision: -4730000.00
DML.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.04
DML.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1106310000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 565252000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 305112000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 260140000.00
DML.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 23898000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 846170000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 521200000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 803687000.00
DML.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -88090000.00
DML.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -88090000.00
DML.TO cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -10455000.00
DML.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 542627000.00
DMLP cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 2319000.00
DMLP cash_flow (annual, 2021-12-31) — Sale Of Business: 2319000.00
DMLP income_statement (annual, 2022-12-31) — +Operating Expense: 8221000.00
DMLP income_statement (annual, 2022-12-31) — +Total Revenue: 170800000.00
DMLP balance_sheet (annual, 2022-12-31) — Accounts Payable: 3131000.00
DMLP balance_sheet (annual, 2022-12-31) — Accounts Receivable: 14543000.00
DMLP balance_sheet (annual, 2022-12-31) — Accrued Interest Receivable: 7170000.00
DMLP balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -361146000.00
DMLP income_statement (annual, 2022-12-31) — Basic Average Shares: 37624000.00
DMLP income_statement (annual, 2022-12-31) — Basic EPS: 3.35
DMLP cash_flow (annual, 2022-12-31) — Beginning Cash Position: 28306000.00
DMLP balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1594000.00
DMLP balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 40754000.00
DMLP balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 40754000.00
DMLP cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -136693000.00
DMLP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -136693000.00
DMLP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 2089000.00
DMLP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 147052000.00
DMLP cash_flow (annual, 2022-12-31) — Change In Account Payable: 930000.00
DMLP cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -291000.00
DMLP cash_flow (annual, 2022-12-31) — Change In Payable: 930000.00
DMLP cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 930000.00
DMLP cash_flow (annual, 2022-12-31) — Change In Receivables: -3486000.00
DMLP cash_flow (annual, 2022-12-31) — Change In Working Capital: -2847000.00
DMLP cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -3138000.00
DMLP cash_flow (annual, 2022-12-31) — Changes In Cash: 12448000.00
DMLP cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -136693000.00
DMLP balance_sheet (annual, 2022-12-31) — Common Stock Equity: 171518000.00
DMLP income_statement (annual, 2022-12-31) — Cost Of Revenue: 31972000.00
DMLP balance_sheet (annual, 2022-12-31) — Current Assets: 62467000.00
DMLP balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 281000.00
DMLP balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 281000.00
DMLP balance_sheet (annual, 2022-12-31) — Current Liabilities: 3412000.00
DMLP cash_flow (annual, 2022-12-31) — Depreciation: 19292000.00
DMLP cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 19292000.00
DMLP cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 19292000.00
DMLP income_statement (annual, 2022-12-31) — Diluted Average Shares: 37624000.00
DMLP income_statement (annual, 2022-12-31) — Diluted EPS: 3.35
DMLP income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 126121000.00
DMLP income_statement (annual, 2022-12-31) — EBIT: 130607000.00
DMLP income_statement (annual, 2022-12-31) — EBITDA: 149899000.00
DMLP cash_flow (annual, 2022-12-31) — End Cash Position: 40754000.00
DMLP cash_flow (annual, 2022-12-31) — Financing Cash Flow: -136693000.00
DMLP cash_flow (annual, 2022-12-31) — Free Cash Flow: 147052000.00
DMLP income_statement (annual, 2022-12-31) — General And Administrative Expense: 8221000.00
DMLP balance_sheet (annual, 2022-12-31) — General Partnership Capital: 676000.00
DMLP balance_sheet (annual, 2022-12-31) — Gross PPE: 474922000.00
DMLP income_statement (annual, 2022-12-31) — Gross Profit: 138828000.00
DMLP balance_sheet (annual, 2022-12-31) — Invested Capital: 171518000.00
DMLP cash_flow (annual, 2022-12-31) — Investing Cash Flow: 2089000.00
DMLP balance_sheet (annual, 2022-12-31) — Leases: 989000.00
DMLP balance_sheet (annual, 2022-12-31) — Limited Partnership Capital: 170842000.00
DMLP balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1313000.00
DMLP balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1313000.00
DMLP cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 2089000.00
DMLP income_statement (annual, 2022-12-31) — Net Income: 130607000.00
DMLP income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 126121000.00
DMLP income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 130607000.00
DMLP income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 130607000.00
DMLP income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 130607000.00
DMLP cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 130607000.00
DMLP income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 130607000.00
DMLP balance_sheet (annual, 2022-12-31) — Net PPE: 113776000.00
DMLP cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 2089000.00
DMLP balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 0.00
DMLP income_statement (annual, 2022-12-31) — Normalized EBITDA: 149899000.00
DMLP income_statement (annual, 2022-12-31) — Normalized Income: 130607000.00
DMLP cash_flow (annual, 2022-12-31) — Operating Cash Flow: 147052000.00
DMLP income_statement (annual, 2022-12-31) — Operating Income: 130607000.00
DMLP income_statement (annual, 2022-12-31) — Operating Revenue: 170130000.00
DMLP balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 38371493.00
DMLP income_statement (annual, 2022-12-31) — Other Gand A: 8221000.00
DMLP balance_sheet (annual, 2022-12-31) — Other Properties: 959000.00
DMLP balance_sheet (annual, 2022-12-31) — Payables: 3131000.00
DMLP balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3131000.00
DMLP income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 4486000.00
DMLP income_statement (annual, 2022-12-31) — Pretax Income: 130607000.00
DMLP balance_sheet (annual, 2022-12-31) — Receivables: 21713000.00
DMLP income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 31972000.00
DMLP income_statement (annual, 2022-12-31) — Reconciled Depreciation: 19292000.00
DMLP cash_flow (annual, 2022-12-31) — Sale Of Business: 2089000.00
DMLP cash_flow (annual, 2022-12-31) — Sale Of PPE: 2089000.00
DMLP income_statement (annual, 2022-12-31) — Selling General And Administration: 8221000.00
DMLP balance_sheet (annual, 2022-12-31) — Share Issued: 38371493.00
DMLP balance_sheet (annual, 2022-12-31) — Stockholders Equity: 0.00
DMLP balance_sheet (annual, 2022-12-31) — Tangible Book Value: 171518000.00
DMLP income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
DMLP income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
DMLP balance_sheet (annual, 2022-12-31) — Total Assets: 176243000.00
DMLP balance_sheet (annual, 2022-12-31) — Total Capitalization: 171518000.00
DMLP balance_sheet (annual, 2022-12-31) — Total Debt: 1594000.00
DMLP balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 171518000.00
DMLP income_statement (annual, 2022-12-31) — Total Expenses: 40193000.00
DMLP balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4725000.00
DMLP balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 113776000.00
DMLP balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1313000.00
DMLP balance_sheet (annual, 2022-12-31) — Total Partnership Capital: 171518000.00
DMLP balance_sheet (annual, 2022-12-31) — Working Capital: 59055000.00
DMLP income_statement (annual, 2023-12-31) — +Operating Expense: 11164000.00
DMLP income_statement (annual, 2023-12-31) — +Total Revenue: 163799000.00
DMLP balance_sheet (annual, 2023-12-31) — Accounts Payable: 4195000.00
DMLP balance_sheet (annual, 2023-12-31) — Accounts Receivable: 14407000.00
DMLP balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 8275000.00
DMLP balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -387453000.00
DMLP income_statement (annual, 2023-12-31) — Basic Average Shares: 38783000.00
DMLP income_statement (annual, 2023-12-31) — Basic EPS: 2.85
DMLP cash_flow (annual, 2023-12-31) — Beginning Cash Position: 40754000.00
DMLP balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1313000.00
DMLP balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 47025000.00
DMLP balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 47025000.00
DMLP cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -135855000.00
DMLP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -135855000.00
DMLP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 2284000.00